High expression of CDK6 confers resistance to fulvestrant in breast cancer cells and is a potential predictor of fulvestrant treatment failure in estrogen receptor-positive breast cancer

Carla Maria Lourenco Alves, Daniel Elias, Maria Bibi Lyng, Martin Bak, Anne Elisabeth Lykkesfeldt, Henrik Ditzel

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

94 Downloads (Pure)
OriginalsprogEngelsk
Publikationsdato7. feb. 2015
StatusUdgivet - 7. feb. 2015
BegivenhedAACR Meeting Translation of the Cancer Genome - San Francisco, USA
Varighed: 7. feb. 20159. feb. 2015

Konference

KonferenceAACR Meeting Translation of the Cancer Genome
LandUSA
BySan Francisco
Periode07/02/201509/02/2015

Citationsformater

Alves, C. M. L., Elias, D., Lyng, M. B., Bak, M., Lykkesfeldt, A. E., & Ditzel, H. (2015). High expression of CDK6 confers resistance to fulvestrant in breast cancer cells and is a potential predictor of fulvestrant treatment failure in estrogen receptor-positive breast cancer. Poster session præsenteret på AACR Meeting Translation of the Cancer Genome, San Francisco, USA.